25 results
8-K
EX-99.2
KRYS
Krystal Biotech Inc
17 Nov 22
Regulation FD Disclosure
8:33am
during B-VEC clinical development program Vector data package includes B-VEC Phase 1/2 and Phase 3 studies, two clinical stage programs, and multiple
8-K
EX-1.1
umjj83utr lc4m
3 Dec 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-1.1
shk3ceyvw71xcd1rt
5 Feb 21
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-1.1
5lhe vqeidbo4rnd3nv
21 May 20
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-1.1
tzeqfq9 55bxr9q7auu
27 Jun 19
Entry into a Material Definitive Agreement
4:28pm